FLT3 and acute myeloid leukemia: We propose that factors such as STAT5 might play an important role, but which transcription factors downstream of FLT3-ITDs participate in these signaling networks is under current investigation, also in a larger cohort of AML patients at the subclonal level by performing transcriptome and chromatin accessibility studies, in line with our previous work7.